Education
About Us
Working with TipRanks
Follow Us
Pulmatrix (PULM)
NASDAQ:PULM
PULM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.78 - $10.40
Previous CloseN/A
Volume31.27K
Average Volume (3M)20.91K
Market Cap
$31.77M
Enterprise Value-$21.39M
Total Cash (Recent Filing)$7.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.40
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding3,652,285
10 Day Avg. Volume22,296
30 Day Avg. Volume20,913
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.43
Price to Sales (P/S)0.00
P/FCF Ratio-0.69
Enterprise Value/Market Cap-0.67
Enterprise Value/Revenue-0.69
Enterprise Value/Gross Profit-12.16
Enterprise Value/Ebitda0.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pulmatrix News
PremiumCompany Announcements
Pulmatrix Stockholders Approve Merger with Cullgen
PremiumCompany Announcements
Pulmatrix Reports 2024 Financials and Merger Plans
PremiumCompany Announcements
Pulmatrix and Cullgen Announce Strategic Merger Agreement
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.08% Mutual Funds
<0.01% Other Institutional Investors
96.50% Public Companies and
Individual Investors
PULM FAQ
What was Pulmatrix’s price range in the past 12 months?
Pulmatrix lowest stock price was $1.78 and its highest was $10.40 in the past 12 months.
What is Pulmatrix’s market cap?
Pulmatrix’s market cap is $31.77M.
When is Pulmatrix’s upcoming earnings report date?
Pulmatrix’s upcoming earnings report date is Aug 06, 2025 which is in 49 days.
How were Pulmatrix’s earnings last quarter?
Pulmatrix released its earnings results on May 15, 2025. The company reported -$0.495 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.495.
Is Pulmatrix overvalued?
According to Wall Street analysts Pulmatrix’s price is currently Overvalued.
Does Pulmatrix pay dividends?
Pulmatrix does not currently pay dividends.
What is Pulmatrix’s EPS estimate?
Pulmatrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pulmatrix have?
Pulmatrix has 3,652,285 shares outstanding.
What happened to Pulmatrix’s price movement after its last earnings report?
Pulmatrix reported an EPS of -$0.495 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.536%.
Which hedge fund is a major shareholder of Pulmatrix?
Currently, no hedge funds are holding shares in PULM
Pulmatrix Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
353.83%
12-Months-Change
Fundamentals
Return on Equity
-93.19%
Trailing 12-Months
Asset Growth
-73.51%
Trailing 12-Months
Company Description
Pulmatrix
Pulmatrix, Inc. (PULM) is a clinical-stage biopharmaceutical company that specializes in developing inhaled therapies to address serious pulmonary diseases. Operating in the biotechnology and healthcare sectors, the company focuses on leveraging its proprietary iSPERSE™ technology, a dry powder delivery platform, to create novel inhaled treatments. Pulmatrix's core products aim to treat a range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.